Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Vaccine ; 23(4): 427-34, 2004 Dec 09.
Artigo em Inglês | MEDLINE | ID: mdl-15530690

RESUMO

This study investigated the immune response and safety in 430 adults, when boosted more than 3 years after primary or booster TBE immunisation as measured by neutralization test (NT) and ELISA. Tested by NT, the post-booster day 21 geometric mean titer (GMT) was 331 and 142 for the 18-49 and > or =50 years old, respectively. The post-/pre-booster geometric mean titer ratio (GMR) was 2.29 for the 18-49 years old and 3.21 for the > or =50 years old. An at least four-fold increase of neutralizing TBE antibodies was observed in only 26 and 38% of subjects aged 18-49 and > or =50 years, respectively. The booster effect in subjects with only the primary vaccination course prior to study entry clearly depended on the time elapsed since last TBE vaccination with an estimated annual decline rate of 15%. In subjects with at least one additional booster vaccination virtually no antibody decline was observed. This study clearly indicates that (1) adults may be effectively and safely boosted with a different TBE vaccine and (2) following four immunisations protective antibodies can be detected far beyond a period of 3 years, thus, strongly supporting the reconsideration of currently recommended booster intervals.


Assuntos
Encefalite Transmitida por Carrapatos/prevenção & controle , Imunização Secundária , Vacinas Virais/imunologia , Adolescente , Adulto , Fatores Etários , Idoso , Anticorpos Antivirais/sangue , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunização Secundária/efeitos adversos , Masculino , Pessoa de Meia-Idade , Testes de Neutralização , Fatores de Tempo , Vacinas Virais/administração & dosagem , Vacinas Virais/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA